Compounds > cyproterone acetate
Page last updated: 2024-08-21

cyproterone acetate and Venous Thromboembolism

cyproterone acetate has been researched along with Venous Thromboembolism in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (11.11)29.6817
2010's8 (88.89)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Conard, J; Gompel, A; Horellou, MH; Hugon-Rodin, J; Plu-Bureau, G1
Hugon-Rodin, J; Plu-Bureau, G; Sabbagh, E1
Amy, JJ; Beerthuizen, R; Birkhäuser, M; Bitzer, J; Bombas, T; Creinin, M; Darney, PD; Gemzell-Danielsson, K; Imthurn, B; Jensen, JT; Kaunitz, AM; Kubba, A; Lech, MM; Mansour, D; Merki, G; Rabe, T; Sedlecki, K; Serfaty, D; Seydoux, J; Shulman, LP; Sitruk-Ware, R; Skouby, SO; Szarewski, A; Trussell, J; Vicente, LF; Westhoff, C2
Terplan, M; Zuckerman, D1
Bitzer, J1
Beasley, R; Braithwaite, I; Shirtcliffe, P; Weatherall, M1
Roberts, H1
Franks, S; Glasier, A; Layton, A1

Other Studies

9 other study(ies) available for cyproterone acetate and Venous Thromboembolism

ArticleYear
Type of Combined Contraceptives, Factor V Leiden Mutation and Risk of Venous Thromboembolism.
    Thrombosis and haemostasis, 2018, Volume: 118, Issue:5

    Topics: Adolescent; Adult; Androstenes; Blood Coagulation Disorders, Inherited; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Factor V; Female; Humans; Incidence; Middle Aged; Paris; Premenopause; Progestins; Risk Factors; Venous Thromboembolism; Young Adult

2018
[Hormonal contraception and vascular risk: CNGOF Contraception Guidelines].
    Gynecologie, obstetrique, fertilite & senologie, 2018, Volume: 46, Issue:12

    Topics: Androstenes; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Desogestrel; Female; France; Humans; Levonorgestrel; Norpregnenes; Progestins; Risk Factors; Vascular Diseases; Venous Thromboembolism

2018
Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism.
    The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2013, Volume: 18, Issue:3

    Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Europe; Female; Humans; Progestins; Risk Assessment; Venous Thromboembolism; Women's Health

2013
Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism.
    The journal of family planning and reproductive health care, 2013, Volume: 39, Issue:3

    Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Europe; Female; Humans; Progestins; Risk Assessment; Venous Thromboembolism; Women's Health

2013
Comment on 'Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism'.
    The journal of family planning and reproductive health care, 2013, Volume: 39, Issue:4

    Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Female; Humans; Progestins; Venous Thromboembolism

2013
Comment on 'Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism': author's response.
    The journal of family planning and reproductive health care, 2013, Volume: 39, Issue:4

    Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Female; Humans; Progestins; Venous Thromboembolism

2013
Anti-androgen contraceptive pills and higher risk of venous thromboembolism.
    The New Zealand medical journal, 2016, Feb-19, Volume: 129, Issue:1430

    Topics: Adolescent; Adult; Aged; Androgen Antagonists; Androstenes; Case-Control Studies; Contraceptives, Oral, Combined; Cyproterone Acetate; Female; Humans; Middle Aged; New Zealand; Risk Factors; Venous Thromboembolism; Young Adult

2016
Hormone-based contraceptive therapy and risk of venous thromboembolism in young women.
    Clinical advances in hematology & oncology : H&O, 2010, Volume: 8, Issue:5

    Topics: Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Female; Hemostasis; Humans; Norpregnenes; Risk Factors; Venous Thromboembolism; Young Adult

2010
Cyproterone acetate/ethinyl estradiol for acne and hirsutism: time to revise prescribing policy.
    Human reproduction (Oxford, England), 2008, Volume: 23, Issue:2

    Topics: Acne Vulgaris; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Hirsutism; Humans; Menstruation Disturbances; Polycystic Ovary Syndrome; Practice Guidelines as Topic; Venous Thromboembolism

2008